Home › PERSISTENT › Filing
🔔 Get instant alerts when PERSISTENT files quarterly results on BSE Start free trial →

The Transcript of the investor/analyst call held on Thursday, October 15, 2026, is as enclosed.

Filed: 23 Oct 2026, 20:45 IST Exchange: BSE Category: Financial Results — Earnings Call Transcript
AI summary - Q2 FY27 revenue USD 487.6mn, +20% y-y, EBIT margin 15%, PAT margin 10.6% - Nagarro acquisition progressing; 94% shares secured, closure expected Q4 CY26/Q1 CY27 - One-time Nagarro acquisition expenses ~$50mn over 3-4 quarters, impacting PAT by ~3.1% - Software Reinvention Services launched, driving AI-led growth and cost optimization - Top 5 customers revenue +38.9% y-y; North America +22.5%, Europe -8.5% (client-specific) - EBIT margin impacted by wage hike, large deal amortization; target 16-17% margin range - Strong deal wins in Software, BFSI, Healthcare; large $650mn+ deal ramping - Cash and investments $315mn; billed DSO improved to 50 days - Multiple AI certifications and partnerships; focus on AI-driven product engineering - Multiple analyst queries on BFSI AI adoption, margin outlook, Nagarro integration
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 PERSISTENT — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
⚡
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add PERSISTENT to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Persistent Systems Limited

Important. The summary above is generated automatically from Persistent Systems Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.